Department of Child and Adolescent Psychiatry, Faculty of Medicine, University of Gaziantep, Gaziantep, Turkey.
Department of Medical Biochemistry, Faculty of Medicine, University of Gaziantep, Gaziantep, Turkey.
Int J Psychiatry Clin Pract. 2019 Nov;23(4):251-257. doi: 10.1080/13651501.2019.1602657. Epub 2019 Jul 24.
Attention-Deficit/Hyperactivity Disorder (ADHD) is a complex neurodevelopmental disorder with strong male predominance. Since Müllerian Inhibiting Substance (MIS) produces sex-linked bias in animal studies, we aimed to investigate the role of MIS, Sex Hormone Binding Globulin (SHBG) and sex hormone levels in boys with ADHD. We compared prepubertal, psychostimulant-naïve boys with ADHD with age-matched healthy control boys (HCs). Patients were re-evaluated after 30 days of methylphenidate treatment assessing ADHD severity, and serum MIS, testosterone, estradiol, and albumin concentrations. Compared to 30 HCs, with ADHD ( = 49, age = 6.9 ± 0.2 years) had lower SHBG ( = .014), and higher free testosterone ( = 0.006) and bioavailable testosterone ( = .002) percentages. Methylphenidate improved ADHD measures (all < .0001) and abnormal baseline hormonal levels, increasing SHBG levels ( = .024), and lowering free ( = .001) and bioavailable testosterone ( = .016) percentages so that only free testosterone percentages remained higher versus HCs post-treatment ( = .02). Compared to age- and sex-matched HCs, prepubertal, stimulant-naïve boys with ADHD had significantly lower SHBG and higher free and bioavailable testosterone percentages, suggesting a possible contribution of sex hormones to ADHD. Osmotic-release oral system methylphenidate treatment for 30 days significantly improved ADHD symptoms and abnormal sex hormone levels, normalizing SHBG and bioavailable testosterone percentages that were similar to HCs while free testosterone remained elevated versus HCs.Key pointsCompare to healthy matched controls prepubertal stimulant-naïve boys with ADHD had significantly lower SHBG and higher free and bioavailable testosterone percentages, suggesting a possible effect on sex hormones to ADHD.After 30-day methylphenidate treatment, ADHD symptoms significantly improved, and SHBG and bioavailable testosterone percentages normalized which were similar to HCs, while free testosterone remained elevated versus HCs.We found a negative relationship between MIS levels and hyperactivity scores in ADHD boys. This finding suggests that MIS may contribute to hyperactivity symptoms, either directly by affecting behavior or indirectly by affecting sex hormone levels.
注意缺陷多动障碍(ADHD)是一种复杂的神经发育障碍,具有明显的男性优势。由于缪勒管抑制物质(MIS)在动物研究中产生了与性别相关的偏倚,我们旨在研究 MIS、性激素结合球蛋白(SHBG)和性激素水平在患有 ADHD 的男孩中的作用。我们比较了未进入青春期、未经精神兴奋剂治疗的 ADHD 男孩和年龄匹配的健康对照组(HCs)。患者在接受 30 天哌醋甲酯治疗后进行重新评估,评估 ADHD 严重程度,以及血清 MIS、睾酮、雌二醇和白蛋白浓度。与 30 名 HCs(=30,年龄=6.9±0.2 岁)相比,ADHD 组的 SHBG 水平较低(=0.014),游离睾酮(=0.006)和生物可利用睾酮(=0.002)百分比较高。哌醋甲酯改善了 ADHD 量表(均<0.0001)和异常的基线激素水平,增加了 SHBG 水平(=0.024),降低了游离(=0.001)和生物可利用睾酮(=0.016)百分比,使得治疗后游离睾酮百分比仍高于 HCs(=0.02)。与年龄和性别匹配的 HCs 相比,未进入青春期、未经兴奋剂治疗的 ADHD 男孩的 SHBG 水平明显较低,游离睾酮和生物可利用睾酮百分比较高,这表明性激素可能对 ADHD 有一定的影响。奥昔布宁控释口服溶液治疗 30 天可显著改善 ADHD 症状和异常的性激素水平,使 SHBG 和生物可利用睾酮百分比正常化,与 HCs 相似,而游离睾酮仍高于 HCs。关键点与健康匹配的对照组相比,未进入青春期、未经兴奋剂治疗的 ADHD 男孩的 SHBG 水平明显较低,游离睾酮和生物可利用睾酮百分比较高,这表明性激素可能对 ADHD 有一定的影响。经过 30 天的哌醋甲酯治疗,ADHD 症状显著改善,SHBG 和生物可利用睾酮百分比正常化,与 HCs 相似,而游离睾酮仍高于 HCs。我们发现 ADHD 男孩的 MIS 水平与多动评分呈负相关。这一发现表明,MIS 可能通过直接影响行为或间接影响性激素水平来导致多动症状。